(Q35563857)

8 August 2017

title

Recent progress in the development of assays suited for histone deacetylase inhibitor screening (English)

1 reference

8 August 2017

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2003.08.008

23 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2003.08.008

23 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2003.08.008

23 March 2024

author name string

Dennis Wegener

1

1 reference

8 August 2017

Christian Hildmann

2

1 reference

8 August 2017

Andreas Schwienhorst

3

1 reference

8 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14567963

23 March 2024

publication date

1 September 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S1096719203001756?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2003.08.008

https://api.elsevier.com/content/article/PII:S1096719203001756?httpAccept=text/plain

23 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2003.08.008

Molecular Genetics and Metabolism

23 March 2024

published in

1 reference

8 August 2017

volume

80

1 reference

8 August 2017

issue

1-2

1 reference

8 August 2017

page(s)

138-147

1 reference

ACETYLATION AND METHYLATION OF HISTONES AND THEIR POSSIBLE ROLE IN THE REGULATION OF RNA SYNTHESIS

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

A direct link between core histone acetylation and transcriptionally active chromatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Nuclease hypersensitive sites in chromatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Histone acetylation reduces nucleosome core particle linking number change

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Histone modification: the 'next wave' in cancer therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Histone acetylation in chromatin structure and transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Histone acetylation: chromatin in action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

HDAC's at work: everyone doing their part

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Deacetylase enzymes: biological functions and the use of small-molecule inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

The BRCA2 is a histone acetyltransferase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Role of the histone deacetylase complex in acute promyelocytic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Amide Analogues of Trichostatin A as Inhibitors of Histone Deacetylase and Inducers of Terminal Cell Differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Inhibitors of histone deacetylase suppress the growth of MCF-7 breast cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Rapid induction of histone hyperacetylation and cellular differentiation in human breast tumor cell lines following degradation of histone deacetylase-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Histone deacetylase as a new target for cancer chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Histone deacetylase as a therapeutic target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Histone-deacetylase inhibitors: novel drugs for the treatment of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Synthesis of a carbohydrate-derived hydroxamic acid inhibitor of the bacterial enzyme (LpxC) involved in lipid A biosynthesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Trichostatin A and structurally related histone deacetylase inhibitors induce 5-lipoxygenase promoter activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Biochemical methods for analysis of histone deacetylases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Characterization of a human RPD3 ortholog, HDAC3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Characterization of pea histone deacetylases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Enzymatic deacetylation of a synthetic peptide fragment of histone H4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Depudecin induces morphological reversion of transformed fibroblasts via the inhibition of histone deacetylase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Development of a scintillation proximity assay for histone deacetylase using a biotinylated peptide derived from histone-H4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

A non-isotopic assay for histone deacetylase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

A fluorogenic histone deacetylase assay well suited for high-throughput activity screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Fluorescence-labeled octapeptides as substrates for histone deacetylase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Improvement and validation of the fluorescence-based histone deacetylase assay using an internal standard

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

A microplate reader-based nonisotopic histone deacetylase activity assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Eosin Y as an internal standard for a plate reader-based quantitation of a histone deacetylase substrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Improved fluorogenic histone deacetylase assay for high-throughput-screening applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Design and synthesis of fluorogenic trypsin peptide substrates based on resonance energy transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Rapid assay processing by integration of dual-color fluorescence cross-correlation spectroscopy: high throughput screening for enzyme activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

A homogeneous nonisotopic histone deacetylase activity assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Fluorescamine: A Reagent for Assay of Amino Acids, Peptides, Proteins, and Primary Amines in the Picomole Range

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

A new amidohydrolase from Bordetella or Alcaligenes strain FB188 with similarities to histone deacetylases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

A fluorescence-based homogeneous assay for measuring activity of UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

A High-Throughput-Screening Method for the Identification of Active and Enantioselective Hydrolases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

A continuous, nonradioactive assay for histone acetyltransferases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Fluorescence intensity multiple distributions analysis: concurrent determination of diffusion times and molecular brightness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Monitoring conformational dynamics of a single molecule by selective fluorescence spectroscopy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

High-throughput screening of small molecules in miniaturized mammalian cell-based assays involving post-translational modifications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Multidimensional chemical genetic analysis of diversity-oriented synthesis-derived deacetylase inhibitors using cell-based assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Chemical genetic modifier screens: small molecule trichostatin suppressors as probes of intracellular histone and tubulin acetylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Expression of 15-lipoxygenase-1 is regulated by histone acetylation in human colorectal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Inhibitors of human histone deacetylase: synthesis and enzyme and cellular activity of straight chain hydroxamates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Smads and early developmental signaling by the TGFbeta superfamily

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Physical and functional interaction of SMADs and p300/CBP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Microarray deacetylation maps determine genome-wide functions for yeast histone deacetylases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Cloning and characterization of a novel human class I histone deacetylase that functions as a transcription repressor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Structure of histone deacetylases: insights into substrate recognition and catalysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Synthesis and histone deacetylase inhibitory activity of new benzamide derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.08.008

Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines

7 January 2021

11

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2003.08.008

Histone deacetylase inhibitors as potential anti-skin cancer agents

23 March 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2003.08.008

23 March 2024

Identifiers

1 reference

8 August 2017

1 reference